Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory

Journal of Invasive Cardiology

Volumn 11, Issue SUPPL. A, 1999, Pages

  Berger, Peter B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

CARDIOVASCULAR DISEASE; HUMAN; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CARDIOVASCULAR DISEASES; HUMANS; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE;

EID: 0001811827     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
2. White CW. Antiplatelet agents are effective in reducing the immediate complications of PTCA: Results from the ticlopidine multicenter trial. Circulation 1987;76:IV-400.